BBIO
NASDAQ · Biotechnology
Bridgebio Pharma Inc
$68.63
-0.29 (-0.42%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-9.46%
1Y
+54.40%
YTD
-12.28%
Open$68.57
Previous Close$68.92
Day High$69.90
Day Low$68.03
52W High$84.94
52W Low$39.65
Volume—
Avg Volume2.36M
Market Cap12.98B
P/E Ratio—
EPS$-3.75
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$75.38
Below
SMA 200
$56.39
Above
RSI (14)
38.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
29 analysts
Price Target
+176.9% upside
Current
$68.63
$68.63
Target
$190.06
$190.06
$141.92
$190.06 avg
$243.96
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 513.43M | 275.59M | 2.34B |
| Net Income | -741,334,771 | -358,132,739 | -436,239,166 |
| Profit Margin | -144.4% | -137.2% | -18.6% |
| EBITDA | -551,329,788 | -281,139,720 | -548,703,476 |
| Free Cash Flow | — | — | -421,297,535 |
| Rev Growth | +86.3% | +86.3% | -0.2% |
| Debt/Equity | 8.27 | 8.27 | 0.84 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |